Kayshild
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kayshild, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: EMA Authorised: Kayshild (semaglutide) — Novo Nordisk A/S
1 regulatory and trial event tracked for Kayshild, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: EMA Authorised: Kayshild (semaglutide) — Novo Nordisk A/S